Navigation Links
Humor as effective as medication in treating agitation in dementia
Date:9/21/2011

Humour therapy is as effective as widely used antipsychotic drugs in managing agitation in patients with dementia and avoids serious drug side effects, a new study shows.

The first major study of the impact of humour therapy on mood, agitation, behavioural disturbances and social engagement in dementia patients found both short term and persisting decrease in agitation, according to lead researcher, Dr Lee-Fay Low, a Research Fellow in the School of Psychiatry at the University of New South Wales.

The SMILE study across 36 Australian residential aged care facilities involved the recruitment and training of a staff member to act as a "LaughterBoss" who worked with a humour practitioner with comedic and improvisation skills not unlike "Clown Doctors" used in hospitals to aid recovery and lift mood in children.

Jean-Paul Bell, the key humour therapist in the SMILE study, has set up the Arts Health Institute (AHI) to train humour practitioners and aged care staff. The AHI's core program, Play Up, provides a playful relationship with residents and staff in aged care, focusing particularly with people with dementia. The AHI is now focused on translating the knowledge of the SMILE study into residential aged care and continues to work with UNSW's Dementia Collaborative Research Centre to roll out the program nationally.

Dementia rates are expected to double to in the next 20 years in Australia to about 450,000, mainly due to an ageing population. About 6.5 per cent of people over 65 and 22 per cent of people over 85 have dementia an umbrella term used to describe up to 60 different conditions causing similar neurodegenerative changes in the brain.

Between 70 and 80 per cent of people suffering from dementia are troubled by agitation, a problem for both patients with the disease and their carers.

"Agitated behaviours include physical and verbal aggression, wandering, screaming and repetitive behaviours and questions. This is challenging for staff and often indicates unmet needs and distress in the residents of aged care facilities," says Dr Low.

The SMILE study found a 20 per cent reduction in agitation using humour therapy, an improvement comparable to the common use of anti-psychotic drugs.

"This shows humour therapy should be considered before medication for agitation, particularly taking into account its side effects."

A major 2009 study for the UK Department of Health found serious side effects of antipsychotics, including thousands of deaths and strokes, linked to the use of these drugs in dementia and recommended a reduction in medication rates and specialised training for carers in non-drug therapies.

In the SMILE study agitation decreased not only during the 12 week humour therapy program, but remained lower at 26 week follow up. Happiness and positive behaviours rose over the 12 weeks of the program, however, dropped as soon as humour practitioner visits ceased.

The SMILE Study results will be presented at the National Dementia Research Forum 2011 on the 22nd and 23rd September.


'/>"/>

Contact: Dr. Lee-Fay Low
LF.Low@unsw.edu.au
61-293-852-599
University of New South Wales
Source:Eurekalert

Related medicine news :

1. New Breast Cancer Book Offers Humor Filled Look at Being Thirty-Something, Single And Getting Through Diagnosis
2. Low forms of cyclin E reduce breast cancer drugs effectiveness
3. Gastric Banding Most Effective for Obese Teens
4. Neuroimaging study may pave way for effective Alzheimers treatments
5. China Cord Blood Corporation Warrant Registration Statement Declared Effective by SEC
6. Charging less for more effective treatments could reduce health care costs while improving health
7. Split-course palliative radiotherapy confirmed as effective treatment for advanced NSCLC
8. New drug for kidney transplant recipients effective in humans
9. Two Sepsis Treatments Look Equally Effective
10. Mammogram Plus MRI Seems Cost-Effective in High-Risk Women
11. Mammogram Plus MRI Cost-Effective in High-Risk Women
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... ... December 08, 2016 , ... The West Virginia Medical Institute ... The name change aligns the entire company with its existing Quality Insights ... , “We are very proud of the achievements associated with the West Virginia ...
(Date:12/8/2016)... (PRWEB) , ... December 08, 2016 , ... ... Donuts Franchising Company LLC, announced the first national #QuackGivesBack campaign which supported ... , “This was our first franchise-wide Quack Gives Back initiative, and ...
(Date:12/8/2016)... ... 08, 2016 , ... Mirixa Corporation , a leading ... pharmacist-delivered patient care services, has announced the promotions of Karen Litsinger to senior ... of sales. , Litsinger joined Mirixa in 2008 after serving as a ...
(Date:12/8/2016)... (PRWEB) , ... December 08, 2016 , ... David ... with global law firm Greenberg Traurig, LLP, will speak at DeviceTalks West, Dec. 12, ... of the DeviceTalks series, and attorneys from the firm’s global Life Sciences & Medical ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... development continuity to its innovative Unified Instance Manager architecture, meeting the needs ... this new version optimizes the unattended auto-dialing system without agents, Presence Robodialer, ...
Breaking Medicine News(10 mins):
(Date:12/9/2016)... , Dec. 9, 2016 aTyr Pharma, Inc. (Nasdaq: ... development of Physiocrine-based therapeutics to address severe, rare diseases, today announced ... upcoming BMO Prescriptions for Success Healthcare Conference at the InterContinental Barclay ... December 14, 2016, at 4:20 p.m. ET. About ... ...
(Date:12/9/2016)... , Dec. 9, 2016 Department of Health ... regulations for medical marijuana dispensaries under Act 16 are ... , and are now available online . ... in the plan for operation; process for dispensing medical ... well as where the dispensary facilities can be located," ...
(Date:12/8/2016)... VIEW, Calif. , Dec. 8, 2016 IRIDEX ... intends to offer newly issued shares of common stock, $0.01 ... pursuant to an underwritten public offering.  The final terms of ... the time of pricing, and there can be no assurance ... IRIDEX expects to use the net proceeds it ...
Breaking Medicine Technology: